GlassScriptPhysician profile
Heather Butler
NPI 1194143966
$527.30
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2022: $11.71.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $135.75 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $118.99 | 2019 | |
| Novo Nordisk INC | $46.13 | 2019 | |
| Lilly USA, LLC | $41.34 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $36.59 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.10 | 2019 | |
| Astellas Pharma US INC | $27.29 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.88 | 2019 | |
| Janssen Pharmaceuticals, INC | $25.61 | 2019 | |
| Abbvie INC. | $14.81 | 2019 | |
| Shire North American Group INC | $12.67 | 2019 | |
| Glaxosmithkline, LLC. | $12.14 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.